Value of Neutrophil to Lymphocyte ratio as a new biomarker in Tuberculosis inflammation
References
- Alsayed, Shahinda S. R., and Hendra Gunosewoyo. “Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets.” International Journal of Molecular Sciences, vol. 24, no. 6, Mar. 2023, https://doi.org/10.3390/ijms24065202.
- Stefanescu, Simona, et al. “Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results.” Pathogens (Basel, Switzerland), vol. 10, no. 7, June 2021, https://doi.org/10.3390/pathogens10070789.
- Kissling, Mirjam, et al. “Monocyte, Lymphocyte and Neutrophil Ratios - Easy-to-Use Biomarkers for the Diagnosis of Pediatric Tuberculosis.” The Pediatric Infectious Disease Journal, vol. 42, no. 6, June 2023, pp. 520–27, https://doi.org/10.1097/INF.0000000000003901.
- Buonacera, Agata, et al. “Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases.” International Journal of Molecular Sciences, vol. 23, no. 7, Mar. 2022, https://doi.org/10.3390/ijms23073636.
- Liu, Hao, et al. “Neutrophil-Lymphocyte Ratio as a Potential Marker for Differential Diagnosis between Spinal Tuberculosis and Pyogenic Spinal Infection.” Journal of Orthopaedic Surgery and Research, vol. 17, no. 1, July 2022, p. 357, https://doi.org/10.1186/s13018-022-03250-x.
- Nakao, Makoto, et al. “Immunonutritional Status and Pulmonary Cavitation in Patients with Tuberculosis: A Revisit with an Assessment of Neutrophil/Lymphocyte Ratio.” Respiratory Investigation, vol. 57, no. 1, Jan. 2019, pp. 60–66, https://doi.org/10.1016/j.resinv.2018.08.007.
- Gumus, F et al. “The effects of smoking on neutrophil/lymphocyte, platelet//lymphocyte ratios.” Bratislavske lekarske listy vol. 119,2 (2018): 116-119. doi:10.4149/BLL_2018_023
- Baluku, Joseph Baruch MMed, MSca,b,*; Nabwana, Martin MScc; Kansiime, Grace MMedd; Nuwagira, Edwin MMedd. Cigarette smoking is associated with an increase in blood monocytes in people with tuberculosis: A cross-sectional study. Medicine 101(37):p e30737, September 16, 2022. | DOI: 10.1097/MD.0000000000030737
- Valdez-Miramontes CE, Martínez LAT, Torres-Juárez F, et al. Nicotine modulates molecules of the innate immune response in epithelial cells and macrophages during infection with M. tuberculosis. Clin Exp Immunol. 2020;199:230–43. Pedersen KM, Çolak Y, Ellervik C, et al. Smoking and increased white and red blood cells. Arterioscler Thromb Vasc Biol. 2019;39:965–77.
- Abakay, Ozlem, et al. “The Relationship between Inflammatory Marker Levels and Pulmonary Tuberculosis Severity.” Inflammation, vol. 38, no. 2, Apr. 2015, pp. 691–96, https://doi.org/10.1007/s10753-014-9978-y.
- Ashenafi, Senait et al. “Anemia Is a Strong Predictor of Wasting, Disease Severity, and Progression, in Clinical Tuberculosis (TB).” Nutrients vol. 14,16 3318. 12 Aug. 2022, doi:10.3390/nu14163318
- Gelaw, Y.; Getaneh, Z.; Melku, M. Anemia as a risk factor for tuberculosis: A systematic review and meta-analysis. Environ. Health Prev. Med. 2021, 26, 13.
- Ganz, Tomas. “Anemia of Inflammation.” The New England journal of medicine vol. 381,12 (2019): 1148-1157. doi:10.1056/NEJMra1804281
- Bekele, A.; Gebreselassie, N.; Ashenafi, S.; Kassa, E.; Aseffa, G.; Amogne, W.; Getachew, M.; Aseffa, A.; Worku, A.; Raqib, R.; et al. Daily adjunctive therapy with vitamin D3 and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: A randomized controlled trial in Ethiopia. J. Intern. Med. 2018, 284, 292–306.
- Luies, L., & du Preez, I. (2020). The Echo of Pulmonary Tuberculosis: Mechanisms of Clinical Symptoms and Other Disease-Induced Systemic Complications. Clinical Microbiology Reviews, 33(4). doi:10.1128/cmr.00036-20.
- Chang, Suzanne W et al. “Gut hormones, appetite suppression and cachexia in patients with pulmonary TB.” PloS one vol. 8,1 (2013): e54564. doi:10.1371/journal.pone.0054564
- Liu, Quan-Xian et al. “Associations between nutritional and immune status and clinicopathologic factors in patients with tuberculosis: A comprehensive analysis.” Frontiers in cellular and infection microbiology vol. 12 1013751. 24 Nov. 2022, doi:10.3389/fcimb.2022.1013751
- Skupien, Erika Cavalheiro et al. “The relation between leptin and inflammatory markers with respiratory and peripheral muscle strength in tuberculosis: A case-control study.” The clinical respiratory journal vol. 12,11 (2018): 2559-2565. doi:10.1111/crj.12956
- Fois, Alessandro G et al. “The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients.” Molecules (Basel, Switzerland) vol. 25,23 5725. 4 Dec. 2020, doi:10.3390/molecules25235725
- Grasselli, Giacomo et al. “Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.” JAMA internal medicine vol. 180,10 (2020): 1345-1355. doi:10.1001/jamainternmed.2020.3539
- Cai, J.; Li, H.; Zhang, C.; Chen, Z.; Liu, H.; Lei, F.; Qin, J.-J.; Liu, Y.-M.; Zhou, F.; Song, X.; et al. The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19. Cell Metab. 2021, 33, 258–269.e3
- Visca, D et al. “Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects.” Pulmonology vol. 27,2 (2021): 151-165. doi:10.1016/j. pulmoe.2020.12.012
- Flores-Lovon, Kevin et al. “Immune responses in COVID-19 and tuberculosis coinfection: A scoping review.” Frontiers in immunology vol. 13 992743. 26 Aug. 2022, doi:10.3389/fimmu.2022.992743
- Estévez, Olivia, et al. “Multi-Parameter Flow Cytometry Immunophenotyping Distinguishes Different Stages of Tuberculosis Infection.” The Journal of Infection, vol. 81, no. 1, July 2020, pp. 57–71, https://doi.org/10.1016/j.jinf.2020.03.064.
- Koc, Ibrahim, and Yusuf Taha Gullu. “C-Reactive Protein Lymphocyte Ratio in the Diagnosis of Pulmonary Tuberculosis.” Turkish Journal of Internal Medicine, 2022, https://api.semantic-scholar.org/CorpusID:251163930.
- Suryana, Ketut, et al. “High Pretreatment Level of Neutrophil to Lymphocyte Ratio, Monocyte to Lymphocyte Ratio and Other Factors Associated with Delayed Sputum Conversion in Patients with Pulmonary Tuberculosis.” Infection and Drug Resistance, vol. 15, 2022, pp. 5455–62, https://doi.org/10.2147/IDR.S380166.
- Hu, Yanhong, et al. “High Neutrophil-to-Lymphocyte Ratio Is Associated with Poor Clinical Outcome in Patients with Critically Ill Stroke.” Minerva Anestesiologica, vol. 86, no. 9, Sept. 2020, pp. 939–47, https://doi.org/10.23736/S0375-9393.20.14310-4.
- Sulastri, N, Alisjahbana, B, Livia, R. Sahiratmadja, E. “Neutrophil Lymphocyte Ratio among Patients with Pulmonary Tuberculosis and HIV Co-Infection from West Java, Indonesia.” The Indonesian Biomedical Journal, Sept. 2021.
- Miyahara, Reiko, et al. “Predicting the Risk of Pulmonary Tuberculosis Based on the Neutrophil-to-Lymphocyte Ratio at TB Screening in HIV-Infected Individuals.” BMC Infectious Diseases, vol. 19, no. 1, July 2019, p. 667, https://doi.org/10.1186/s12879-019-4292-9
Language: English
Page range: 97 - 104
Published on: Aug 29, 2024
Published by: Romanian Society of Pneumology
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open
Related subjects:
© 2024 Dariana Elena Pătrîntașu, Sárközi Hédi-Katalin, Ionuț Alexandru Rența, Ana Maria Prădatu, Eugeniu Lupușor, Nicolae Demenciuc, Corina Mărginean, Edith Simona Ianoși, Corina Eugenia Budin, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.